LEFTY2 and primary biliary cholangitis: LEFTY2, also known as Left-right determination factor 2, emerged as a potential therapeutic target for PBC due to its strong association with the disease (p-HEIDI = 0.054, PP.H4 = 0.894) based on comprehensive analyses.